FuRui Medical Technology (01696): Lior Moshe DAYAN will serve as Executive Director, Chairman, Nomination Committee and Authorized Representative

Zhitong Finance App News, FuRui Medical Technology (01696) announced that from January 1, 2026, Mr. Liu Yi (Mr. Liu), the current executive director and chairman of the board of directors, will be reassigned as a non-executive director due to the group's job transfer relationship, and will resign as chairman, chairman of the board nomination committee, member of the board remuneration committee, and authorized representative of the company. Mr. Liu will continue to serve as a member of the Nomination Committee.

Mr. Lior Moshe DAYAN (Mr. Dayan), the current executive director and CEO, will serve as Executive Director, Chairman of the Nomination Committee and authorized representative, and will no longer serve as CEO due to the Group's job transfer relationship; Ms. Feng Rongli, the current non-executive director, will serve as a member of the Remuneration Committee; and Mr. Chen Zhifeng, the current independent non-executive director, will serve as a member of the Nomination Committee.

Mr. Eyal BEN David (Mr. Ben David), the current president of the Group's global business, will serve as CEO, and Mr. Li Jiahong (Mr. Li), the company's executive director and chief financial officer, will also serve as the company's co-CEO.

Mr. Wu Yifang (Mr. Wu) has petitioned to resign as a non-executive director of the company due to a job transfer relationship, effective 1 January 2026; and Ms. Caroline Xiaokui JIN (Ms. Jin) has been appointed as a non-executive director with effect from 1 January 2026.